Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
about
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysisThe Natural Course of Non-Alcoholic Fatty Liver DiseaseCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysisOxidative Stress and Liver Cancer: Etiology and Therapeutic TargetsPractical combination therapy based on pathophysiology of type 2 diabetesPrevention of Hepatocellular CarcinomaPharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 StudiesSystematic review: Preventive and therapeutic applications of metformin in liver diseaseImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsOverview and recent trends of systematic reviews and meta-analyses in hepatology.Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Nonalcoholic fatty liver disease and aging: epidemiology to management.Metformin does not improve survival in patients with hepatocellular carcinoma.Chemopreventive strategies in hepatocellular carcinomaHepatocellular carcinoma: clinical frontiers and perspectives.Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.Comparison of Estimates between Cohort and Case-Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study.Diabetes and Hepatitis C: A Two-Way Association.Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma MortalityMetformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease.Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaNon-alcoholic fatty liver disease and diabetes.Primary hepatocellular carcinoma and metabolic syndrome: An update.Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study.Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy.Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseSirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.Interaction between hepatitis C virus and metabolic factors.Spontaneous regression of hepatocellular carcinoma in a Caucasian male patient: A case report and review of the literatureGlucose intolerance and hepatocellular carcinoma: recent findings for old diseases.Diabetes and cancer relationships.Statin a day keeps cancer at bay.
P2860
Q26738743-8D0A7553-9661-45C8-85F6-98AB4A6A4E97Q26746947-B931AB1E-7E19-4018-B2DB-25F01C46226FQ26824893-600525ED-6D61-4B21-8073-6D0CA680545FQ27306002-4B785F09-E76E-41BF-9B8B-5501E213F3B5Q28071678-6401A505-5953-4992-BFD5-8DEE1E6BF9D4Q28076530-382BE17F-27A7-44FE-A65D-67FB49935715Q28079576-89A35518-442B-4CF0-B3AB-F8465CA0C3EEQ28084927-C2429F3A-635F-475A-8395-69CB88BFC054Q28085535-AFCCDC55-A340-4FE8-98D6-FC2D99C9FB7EQ28535372-AB82A071-C3E9-4290-8DD6-DF7CAC98E9D9Q30239808-871F2097-C553-465E-B90F-0775C698C789Q30434752-14E10AAE-FC53-4EB0-ADBC-CE24A553E5BDQ33672932-F886846E-061B-4BB0-994D-5D6580BA2E94Q34366861-0AFD782E-BCA4-44C6-BD6F-92531B8411A6Q34499122-92B2B6B4-CC30-4369-B8B3-A8DC2403EA07Q35101365-89FDACD2-910D-4CEC-9405-23FD43EC6C08Q35112053-96E326F0-F9B9-4968-8783-AAA9E6FD1485Q35447135-5C46F6DA-24A7-456E-ABDA-72815E03EA63Q35619104-3DCDB68A-F829-47BE-B86E-7BA076546418Q35678036-8C25199E-4ABC-4438-B19B-346D60CBBB61Q36012112-054FBBB4-B67A-4AD6-9613-DAC335CAA01CQ36056076-FADC9067-5F70-46C6-8B59-3E1AB20CA085Q36136847-2FE368D8-8EB8-46D1-8152-AD6CF0B18A78Q36182935-7594F81F-A317-4652-BD1F-2D6666905211Q36580952-3CF4F1E1-64F2-4483-8577-0395566F802DQ36788544-7F10733E-61E9-4C21-924C-669E18FDCBACQ36818830-A6D41C26-FFB3-4FB9-8E02-E132CBB4B63FQ37031730-F6CEDEF2-CD2B-4CF1-B954-935103CE1BD4Q37091659-EBCE5352-E818-44D2-9B20-247C0E670109Q37196508-88AA22A6-2031-4E6E-B70E-BC1176F49740Q37206477-92C27F21-16FC-47FD-A3E0-2814C1D54272Q37328172-18EEF488-DEE8-45A9-BBF4-F0EEBE3FCC5CQ37389382-4AA7CC83-115F-4318-9FF1-DCE7D6C6E19AQ37596189-B236F244-F1F0-428E-8263-E95895476B05Q37641827-50A44C9B-9911-4033-9D6F-027FF53E853FQ37654443-F2DC3234-C1DB-4C8D-A07F-3D3B9A1371A4Q37701757-DBBCA974-FF29-4C29-8216-6B49AC95BBE7Q37722922-895C99FD-E83D-47A2-87EE-CFB247840C3FQ38097984-24A5AC9A-4FA4-446B-BCD0-C08594CB0867Q38108604-ADFC0E9F-3D36-4823-9D78-AEE81856CB59
P2860
Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anti-diabetic medications and ...... atic review and meta-analysis.
@en
type
label
Anti-diabetic medications and ...... atic review and meta-analysis.
@en
prefLabel
Anti-diabetic medications and ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
Anti-diabetic medications and ...... atic review and meta-analysis.
@en
P2093
Abha Goyal Singh
Siddharth Singh
William Sanchez
P2860
P304
881-91; quiz 892
P356
10.1038/AJG.2013.5
P407
P577
2013-02-05T00:00:00Z